Prolonged hemodynamic benefits from a high‐dose bolus injection of human atrial natriuretic factor in congestive heart failure View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1991-11

AUTHORS

Thomas D Giles, Antonio C Quiroz, Louise E Roffidal, Harold Marder, Gary E Sander

ABSTRACT

The physiologic and potential pharmacologic roles of atrial natriuretic factor in congestive heart failure have remained confusing. We have evaluated the hemodynamic responses to human atrial natriuretic factor [ANF (102-126)] given as bolus intravenous doses of 2.0 or 4.5 micrograms/kg to 12 patients with congestive heart failure. Responses were monitored with pulmonary and systemic arterial catheters in place. By 30 minutes after 4.5 micrograms/kg ANF (n = 6), heart rate decreased from 97 +/- 16 to 91 +/- 15 beats/min, right atrial pressure from 14 +/- 4 to 12 +/- 3 mm Hg, and pulmonary capillary wedge pressure from 33 +/- 3 to 23 +/- 2 mm Hg (all p less than 0.05); responses persisted for 120 minutes. Mean arterial pressure, cardiac index, stroke volume index, and pulmonic and systemic vascular resistances did not change significantly. The 2.0 micrograms/kg ANF dose produced similar responses, but only heart rate and right atrial pressure decreased significantly. No clinically important side effects were noted. High-dose ANF bolus doses can be administered simply and safely and improve hemodynamic parameters in chronic heart failure. Therefore ANF does have pharmacologic activity in heart failure and may have therapeutic potential. More... »

PAGES

557-563

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/clpt.1991.181

DOI

http://dx.doi.org/10.1038/clpt.1991.181

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1018429503

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/1834391


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Atrial Natriuretic Factor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemodynamics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Tulane University", 
          "id": "https://www.grid.ac/institutes/grid.265219.b", 
          "name": [
            "Tulane University School of Medicine Cardiovascular Research Laboratory, Department of Medicine"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giles", 
        "givenName": "Thomas D", 
        "id": "sg:person.01117611063.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117611063.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tulane University", 
          "id": "https://www.grid.ac/institutes/grid.265219.b", 
          "name": [
            "Tulane University School of Medicine Cardiovascular Research Laboratory, Department of Medicine"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Quiroz", 
        "givenName": "Antonio C", 
        "id": "sg:person.01133420652.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133420652.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tulane University", 
          "id": "https://www.grid.ac/institutes/grid.265219.b", 
          "name": [
            "Tulane University School of Medicine Cardiovascular Research Laboratory, Department of Medicine"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Roffidal", 
        "givenName": "Louise E", 
        "id": "sg:person.016347567377.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016347567377.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tulane University", 
          "id": "https://www.grid.ac/institutes/grid.265219.b", 
          "name": [
            "Tulane University School of Medicine Cardiovascular Research Laboratory, Department of Medicine"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Marder", 
        "givenName": "Harold", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tulane University", 
          "id": "https://www.grid.ac/institutes/grid.265219.b", 
          "name": [
            "Tulane University School of Medicine Cardiovascular Research Laboratory, Department of Medicine"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sander", 
        "givenName": "Gary E", 
        "id": "sg:person.01264610066.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264610066.05"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1991-11", 
    "datePublishedReg": "1991-11-01", 
    "description": "The physiologic and potential pharmacologic roles of atrial natriuretic factor in congestive heart failure have remained confusing. We have evaluated the hemodynamic responses to human atrial natriuretic factor [ANF (102-126)] given as bolus intravenous doses of 2.0 or 4.5 micrograms/kg to 12 patients with congestive heart failure. Responses were monitored with pulmonary and systemic arterial catheters in place. By 30 minutes after 4.5 micrograms/kg ANF (n = 6), heart rate decreased from 97 +/- 16 to 91 +/- 15 beats/min, right atrial pressure from 14 +/- 4 to 12 +/- 3 mm Hg, and pulmonary capillary wedge pressure from 33 +/- 3 to 23 +/- 2 mm Hg (all p less than 0.05); responses persisted for 120 minutes. Mean arterial pressure, cardiac index, stroke volume index, and pulmonic and systemic vascular resistances did not change significantly. The 2.0 micrograms/kg ANF dose produced similar responses, but only heart rate and right atrial pressure decreased significantly. No clinically important side effects were noted. High-dose ANF bolus doses can be administered simply and safely and improve hemodynamic parameters in chronic heart failure. Therefore ANF does have pharmacologic activity in heart failure and may have therapeutic potential.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/clpt.1991.181", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1017409", 
        "issn": [
          "0009-9236", 
          "1532-6535"
        ], 
        "name": "Clinical Pharmacology & Therapeutics", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5-1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "50"
      }
    ], 
    "name": "Prolonged hemodynamic benefits from a high\u2010dose bolus injection of human atrial natriuretic factor in congestive heart failure", 
    "pagination": "557-563", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "57cfa2ea80948c54ecaea498ef8d1ec6ef43235f26bf87346929640d7a12fd66"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "1834391"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0372741"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/clpt.1991.181"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1018429503"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/clpt.1991.181", 
      "https://app.dimensions.ai/details/publication/pub.1018429503"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:07", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000031.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://onlinelibrary.wiley.com/doi/10.1038/clpt.1991.181/abstract"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/clpt.1991.181'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/clpt.1991.181'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/clpt.1991.181'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/clpt.1991.181'


 

This table displays all metadata directly associated to this object as RDF triples.

132 TRIPLES      20 PREDICATES      38 URIs      30 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/clpt.1991.181 schema:about N15bbaace247a4e6c9b4386ade190474a
2 N3e27ce7041f44ae5a9ac6dffbbc555ac
3 N53f62a6385054471ac793da345c520b9
4 N5d0a574bedc449a182e74f333de05794
5 N5fd06c602bfd409baa386c9cf4c7a90c
6 N8dcb69ac667f4cde9d5c5ff4e8f4e785
7 Nd0e4ad9126fa466791e5394cd9f30823
8 Nde472d818f374a9bb6793efbc7f8ba29
9 Ne608b73ef69944e4bf90f486b721863e
10 anzsrc-for:11
11 anzsrc-for:1102
12 schema:author N23ac7ba719544c099d5cbf0a1141bb9c
13 schema:datePublished 1991-11
14 schema:datePublishedReg 1991-11-01
15 schema:description The physiologic and potential pharmacologic roles of atrial natriuretic factor in congestive heart failure have remained confusing. We have evaluated the hemodynamic responses to human atrial natriuretic factor [ANF (102-126)] given as bolus intravenous doses of 2.0 or 4.5 micrograms/kg to 12 patients with congestive heart failure. Responses were monitored with pulmonary and systemic arterial catheters in place. By 30 minutes after 4.5 micrograms/kg ANF (n = 6), heart rate decreased from 97 +/- 16 to 91 +/- 15 beats/min, right atrial pressure from 14 +/- 4 to 12 +/- 3 mm Hg, and pulmonary capillary wedge pressure from 33 +/- 3 to 23 +/- 2 mm Hg (all p less than 0.05); responses persisted for 120 minutes. Mean arterial pressure, cardiac index, stroke volume index, and pulmonic and systemic vascular resistances did not change significantly. The 2.0 micrograms/kg ANF dose produced similar responses, but only heart rate and right atrial pressure decreased significantly. No clinically important side effects were noted. High-dose ANF bolus doses can be administered simply and safely and improve hemodynamic parameters in chronic heart failure. Therefore ANF does have pharmacologic activity in heart failure and may have therapeutic potential.
16 schema:genre research_article
17 schema:inLanguage en
18 schema:isAccessibleForFree false
19 schema:isPartOf N57c3207a1f9448f18268231243364d40
20 N733b161d97a247be9310ee956920530c
21 sg:journal.1017409
22 schema:name Prolonged hemodynamic benefits from a high‐dose bolus injection of human atrial natriuretic factor in congestive heart failure
23 schema:pagination 557-563
24 schema:productId N4f348ee5a185412f9b38e966985ca2dc
25 Nabaf93c5431f47bd8e598a39bdb8e849
26 Nc32861b230214f0398f24ab1a6e3e57a
27 Ndb42f8fa36c94a1bb56ce185bbcf28a5
28 Ne1b38b6478374b2490ececc5fb385652
29 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018429503
30 https://doi.org/10.1038/clpt.1991.181
31 schema:sdDatePublished 2019-04-10T16:07
32 schema:sdLicense https://scigraph.springernature.com/explorer/license/
33 schema:sdPublisher N843201bf596c4f66aabd2d32e2a70e17
34 schema:url http://onlinelibrary.wiley.com/doi/10.1038/clpt.1991.181/abstract
35 sgo:license sg:explorer/license/
36 sgo:sdDataset articles
37 rdf:type schema:ScholarlyArticle
38 N0a9911ceff424c7da4a47552ad5da3b2 rdf:first sg:person.01264610066.05
39 rdf:rest rdf:nil
40 N143e1c552979445583fab7bd90cd5743 schema:affiliation https://www.grid.ac/institutes/grid.265219.b
41 schema:familyName Marder
42 schema:givenName Harold
43 rdf:type schema:Person
44 N15bbaace247a4e6c9b4386ade190474a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
45 schema:name Injections, Intravenous
46 rdf:type schema:DefinedTerm
47 N23ac7ba719544c099d5cbf0a1141bb9c rdf:first sg:person.01117611063.57
48 rdf:rest Nc0944fac0249477c944079caa663d621
49 N3e27ce7041f44ae5a9ac6dffbbc555ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
50 schema:name Atrial Natriuretic Factor
51 rdf:type schema:DefinedTerm
52 N4f348ee5a185412f9b38e966985ca2dc schema:name doi
53 schema:value 10.1038/clpt.1991.181
54 rdf:type schema:PropertyValue
55 N53f62a6385054471ac793da345c520b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
56 schema:name Humans
57 rdf:type schema:DefinedTerm
58 N57c3207a1f9448f18268231243364d40 schema:volumeNumber 50
59 rdf:type schema:PublicationVolume
60 N57edc5c7fda94ba6997ccb81642bae2e rdf:first sg:person.016347567377.53
61 rdf:rest N858a6cb29ac34481b6c3651a7070f05b
62 N5d0a574bedc449a182e74f333de05794 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Dose-Response Relationship, Drug
64 rdf:type schema:DefinedTerm
65 N5fd06c602bfd409baa386c9cf4c7a90c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Heart Failure
67 rdf:type schema:DefinedTerm
68 N733b161d97a247be9310ee956920530c schema:issueNumber 5-1
69 rdf:type schema:PublicationIssue
70 N843201bf596c4f66aabd2d32e2a70e17 schema:name Springer Nature - SN SciGraph project
71 rdf:type schema:Organization
72 N858a6cb29ac34481b6c3651a7070f05b rdf:first N143e1c552979445583fab7bd90cd5743
73 rdf:rest N0a9911ceff424c7da4a47552ad5da3b2
74 N8dcb69ac667f4cde9d5c5ff4e8f4e785 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Middle Aged
76 rdf:type schema:DefinedTerm
77 Nabaf93c5431f47bd8e598a39bdb8e849 schema:name pubmed_id
78 schema:value 1834391
79 rdf:type schema:PropertyValue
80 Nc0944fac0249477c944079caa663d621 rdf:first sg:person.01133420652.51
81 rdf:rest N57edc5c7fda94ba6997ccb81642bae2e
82 Nc32861b230214f0398f24ab1a6e3e57a schema:name nlm_unique_id
83 schema:value 0372741
84 rdf:type schema:PropertyValue
85 Nd0e4ad9126fa466791e5394cd9f30823 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Aged
87 rdf:type schema:DefinedTerm
88 Ndb42f8fa36c94a1bb56ce185bbcf28a5 schema:name dimensions_id
89 schema:value pub.1018429503
90 rdf:type schema:PropertyValue
91 Nde472d818f374a9bb6793efbc7f8ba29 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Male
93 rdf:type schema:DefinedTerm
94 Ne1b38b6478374b2490ececc5fb385652 schema:name readcube_id
95 schema:value 57cfa2ea80948c54ecaea498ef8d1ec6ef43235f26bf87346929640d7a12fd66
96 rdf:type schema:PropertyValue
97 Ne608b73ef69944e4bf90f486b721863e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Hemodynamics
99 rdf:type schema:DefinedTerm
100 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
101 schema:name Medical and Health Sciences
102 rdf:type schema:DefinedTerm
103 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
104 schema:name Cardiorespiratory Medicine and Haematology
105 rdf:type schema:DefinedTerm
106 sg:journal.1017409 schema:issn 0009-9236
107 1532-6535
108 schema:name Clinical Pharmacology & Therapeutics
109 rdf:type schema:Periodical
110 sg:person.01117611063.57 schema:affiliation https://www.grid.ac/institutes/grid.265219.b
111 schema:familyName Giles
112 schema:givenName Thomas D
113 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117611063.57
114 rdf:type schema:Person
115 sg:person.01133420652.51 schema:affiliation https://www.grid.ac/institutes/grid.265219.b
116 schema:familyName Quiroz
117 schema:givenName Antonio C
118 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133420652.51
119 rdf:type schema:Person
120 sg:person.01264610066.05 schema:affiliation https://www.grid.ac/institutes/grid.265219.b
121 schema:familyName Sander
122 schema:givenName Gary E
123 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264610066.05
124 rdf:type schema:Person
125 sg:person.016347567377.53 schema:affiliation https://www.grid.ac/institutes/grid.265219.b
126 schema:familyName Roffidal
127 schema:givenName Louise E
128 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016347567377.53
129 rdf:type schema:Person
130 https://www.grid.ac/institutes/grid.265219.b schema:alternateName Tulane University
131 schema:name Tulane University School of Medicine Cardiovascular Research Laboratory, Department of Medicine
132 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...